Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

SELL
$30.46 - $46.04 $33,506 - $50,644
-1,100 Reduced 32.14%
2,323 $71,000
Q1 2023

May 10, 2023

BUY
$29.72 - $41.45 $5,944 - $8,290
200 Added 6.21%
3,423 $109,000
Q3 2022

Nov 14, 2022

BUY
$22.51 - $38.27 $72,549 - $123,344
3,223 New
3,223 $94,000
Q4 2021

Feb 02, 2022

SELL
$63.78 - $97.86 $21.7 Million - $33.3 Million
-340,267 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$45.58 - $88.24 $26.3 Million - $50.9 Million
-576,482 Reduced 62.88%
340,267 $54.3 Million
Q2 2021

Aug 12, 2021

SELL
$34.4 - $48.34 $5.06 Million - $7.11 Million
-147,124 Reduced 13.83%
916,749 $86.8 Million
Q1 2021

May 14, 2021

BUY
$23.17 - $38.3 $24.6 Million - $40.7 Million
1,063,873 New
1,063,873 $77 Million

Others Institutions Holding INMD

About InMode Ltd.


  • Ticker INMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,081,104
  • Market Cap $1.49B
  • Description
  • InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedur...
More about INMD
Track This Portfolio

Track Van Berkom & Associates Inc. Portfolio

Follow Van Berkom & Associates Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Berkom & Associates Inc., based on Form 13F filings with the SEC.

News

Stay updated on Van Berkom & Associates Inc. with notifications on news.